Trial intelligence / Profile preview

Effect of early eplerenone after acute myocardial infarction

2014-005407-24Phase 3Completed

Sponsor
Institute for Clinical and Experimental Medicine
Start
Feb 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of eplerenone in myocardial infarction (MI) and Left ventricular remodeling (LVR), sponsored by Institute for Clinical and Experimental Medicine. Started Feb 2015; status: completed.

02

Drugs

eplerenone
03

Conditions

myocardial infarction (MI)Left ventricular remodeling (LVR)

Beyond the preview

Go deeper on 2014-005407-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005407-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call